Physician profile
Daniel Wiznia
NPI 1740548023
$43,962.03
in general payments reported to CMS, 2019-2025
10 companies · $12K in 2025
The $12K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $1,842 · 2021: $3,818 · 2022: $2,039 · 2023: $6,320 · 2024: $1,183 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,400 · Travel and Lodging: $2,544 · Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,443.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,400.00 |
| Travel and Lodging | $2,543.72 |
| Food and Beverage | $470.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $21,578.73 | 2021-2025 | Genflex2 Total Knee System, Legacy Stelkast Knee, Actify 3d |
| Zimmer Biomet Holdings, INC. | $10,842.66 | 2019-2021 | |
| Smith+Nephew, INC. | $8,402.06 | 2019-2020 | |
| Intellijoint Surgical INC. | $1,750.00 | 2019-2021 | |
| Stryker Corporation | $1,074.14 | 2019-2025 | Mako, Insignia |
| Biocomposites INC | $157.90 | 2019 | |
| Conformis, INC. | $132.86 | 2019 | |
| Maxx Orthopedics, INC. | $23.68 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$174.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wiznia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.